356 related articles for article (PubMed ID: 11060330)
1. Organizing cancer genetics programs: the Swiss model.
Pichert G; Stahel RA
J Clin Oncol; 2000 Nov; 18(21 Suppl):65S-9S. PubMed ID: 11060330
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
3. Establishing a cancer risk evaluation program.
Calzone KA; Stopfer J; Blackwood A; Weber BL
Cancer Pract; 1997; 5(4):228-33. PubMed ID: 9250079
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
5. [Genetic counselling in monogenic cancer syndromes].
Brøndum-Nielsen K; Gerdes AM
Ugeskr Laeger; 2006 Jun; 168(24):2350-4. PubMed ID: 16822419
[TBL] [Abstract][Full Text] [Related]
6. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
Hutson SP
Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
[TBL] [Abstract][Full Text] [Related]
7. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
9. Cancer genetic counseling in public health care hospitals: the experience of three Brazilian services.
Palmero EI; Kalakun L; Schüler-Faccini L; Giugliani R; Regla Vargas F; Rocha JC; Ashton-Prolla P
Community Genet; 2007; 10(2):110-9. PubMed ID: 17380061
[TBL] [Abstract][Full Text] [Related]
10. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
11. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
12. Considerations in genetic counseling for inherited breast cancer predisposition.
Robson ME; Offit K
Semin Radiat Oncol; 2002 Oct; 12(4):362-70. PubMed ID: 12382194
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
14. Genetic evaluation of cancer: the importance of family history.
Chew HK
Tex Med; 2001 Feb; 97(2):40-5. PubMed ID: 11233057
[TBL] [Abstract][Full Text] [Related]
15. Genetics and the multidisciplinary breast center.
Peters JA; Rubinstein WS
Surg Oncol Clin N Am; 2000 Apr; 9(2):367-96. PubMed ID: 10757850
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
Shah MR
Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
18. Patients' resistance to risk information in genetic counseling for BRCA1/2.
Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
[TBL] [Abstract][Full Text] [Related]
19. Ethical and scientific considerations for chemoprevention research in cohorts at genetic risk for breast cancer.
Nayfield SG
J Cell Biochem Suppl; 1996; 25():123-30. PubMed ID: 9027608
[TBL] [Abstract][Full Text] [Related]
20. Cancer genetics.
Chapman DD
Semin Oncol Nurs; 2007 Feb; 23(1):2-9. PubMed ID: 17303511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
